 Home > Active Ingredient News > Blood System > The guidelines recommend the "2021 Consensus Guidelines: Diagnosis and Management of Invasive Mycosis Caused by Molds (excluding Aspergillus) in the Department of Hematology/Oncology"

The guidelines recommend the "2021 Consensus Guidelines: Diagnosis and Management of Invasive Mycosis Caused by Molds (excluding Aspergillus) in the Department of Hematology/Oncology"

 Last Update: 2022-01-08
 Source: Internet
 Author: User

Tags

company guidelines

invasive tumor

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Guide name: 2021 Consensus Guide: Diagnosis and management of invasive fungal diseases caused by molds (excluding Aspergillus) in the department of hematology/oncology

Guide name:

English title: Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021

English title:

Issuing agency: Royal Australian College of Physicians (RACP, Royal Australasian College of Physicians)

Release Date: 2021-11-20

release date:

brief introduction:

Invasive mycosis (IFD) caused by unexpected molds of Aspergillus is an important cause of death in patients with malignant tumors/hematopoietic stem cell transplantation

Source: Intern Med J

source:

Download link: Metz Medicine APP
Tip: 78% of users have downloaded Metz Medicine APP , which is more convenient to read and communicate.
Please scan the QR code to download APP Metz Medicine APP directly

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

SULODEXIDE 99% Almost White Powder Dideu-01112 Dideu

CAS No.: 57821-29-1

Pharmacy Grade

$61.76/G EXW

Heparin sodium 9041-08-1 vials safe delivery

CAS No.: 9041-08-1

Pharmacy Grade

$1/G EXW

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.